Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2004
05/06/2004US20040086486 Method of enhancing delivery of a therapeutic nucleic acid
05/06/2004US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells
05/06/2004EP1416281A2 Assay for disease related conformation of a protein
05/06/2004EP1416280A2 Antibodies specific for native PrPsc
05/06/2004EP1416279A1 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein
05/06/2004EP1416272A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson's disease
05/06/2004EP1416051A1 Process for producing nicotinamide adenine dinucleotide phosphate (nadp)
05/06/2004EP1416050A1 Method of modifying enzyme and oxidoreductase variant
05/06/2004EP1416049A1 Method of interfering with a virus infection in plants
05/06/2004EP1416048A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-;defective splicing variant
05/06/2004EP1416047A1 Method of purifying nucleic acid using nonwoven fabric and detection method
05/06/2004EP1416046A1 Use of histamine receptor h3 gene in controlling body weight or food intake
05/06/2004EP1416045A1 Composition containing a fungal cellulase for the treatment of cotton-containing fabrics
05/06/2004EP1416043A1 Leguminous bacterium having potentiated nitrogen fixation ability
05/06/2004EP1415998A2 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
05/06/2004EP1415997A1 Polypeptides relating to signal transfer of advanced glycation end product receptor
05/06/2004EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor
05/06/2004EP1415715A1 Device having multiple molecular arrays
05/06/2004EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
05/06/2004EP1415160A2 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
05/06/2004EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
05/06/2004EP1415152A2 Methods, apparatus, and computer programs for verifying the integrity of a probe
05/06/2004EP1415113A2 Thermal cycling system and method of use
05/06/2004EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization
05/06/2004EP1415005A2 Endogenous retroviruses up-regulated in prostate cancer
05/06/2004EP1415000A1 Method and system for detecting inter-chromosomal imbalance by fluorescent in situ hybridization (fish) on interphase nuclei
05/06/2004EP1414999A1 Antisense modulation of acyl coenzyme a cholesterol acyltransferase-1 expression
05/06/2004EP1414998A1 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants
05/06/2004EP1414996A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
05/06/2004EP1414994A2 Microorganisms and cells for diagnosis and therapy of tumors
05/06/2004EP1414985A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria
05/06/2004EP1414984A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
05/06/2004EP1414982A2 Dna molecules encoding herbicide tolerant acetolactate synthase
05/06/2004EP1414981A2 Fusion proteins for insect control
05/06/2004EP1414980A2 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof
05/06/2004EP1414979A1 Vector for site-specific integration of heterologous dna sequences into the rdna sites of methylotrophic yeasts
05/06/2004EP1414978A1 Novel recombinant gene expression method by stop codon suppression
05/06/2004EP1414976A1 Wheat plants having increased resistance to imidazolinone herbicides
05/06/2004EP1414975A1 Wheat plants having increased resistance to imidazolinone herbicides
05/06/2004EP1414974A2 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
05/06/2004EP1414973A2 Atpase-like molecule and uses thereof
05/06/2004EP1414972A2 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds
05/06/2004EP1414971A2 Salutaridinol 7-o-acetyltransferase and derivatives thereof
05/06/2004EP1414970A2 Production of l-lysine by genetically modified corynebacterium glutamicum strains
05/06/2004EP1414969A2 Biosynthetic genes for butenyl-spinosyn insecticide production
05/06/2004EP1414968A2 Nucleic acids for aminocoumarin biosynthesis
05/06/2004EP1414967A2 Gene associated with leishmania parasite virulence
05/06/2004EP1414966A2 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof
05/06/2004EP1414965A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/06/2004EP1414964A2 Vegf isoform
05/06/2004EP1414963A2 Lipid-associated molecules
05/06/2004EP1414962A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production
05/06/2004EP1414961A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
05/06/2004EP1414959A1 Delivery of dsrna to arthropods
05/06/2004EP1414957A2 Vascular tissue preferred promoters
05/06/2004EP1414954A2 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
05/06/2004EP1414953A2 Identification and cloning of the receptor gene for symbiotic nitrogen fixation
05/06/2004EP1414951A2 Plant growth regulation
05/06/2004EP1414950A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof
05/06/2004EP1414949A1 Cell and transgenic animal modelling human antigenic presentation and their uses
05/06/2004EP1414948A2 Inhibition of apoptosis process and improvement of cell performance
05/06/2004EP1414947A2 Multipotent stem cells from peripheral tissues and uses thereof
05/06/2004EP1414946A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
05/06/2004EP1414941A2 Product and process for transformation of thraustochytriales microorganisms
05/06/2004EP1414940A2 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
05/06/2004EP1414939A2 Seed-preferred regulatory elements and uses thereof
05/06/2004EP1414866A2 Fgf-affinity chromatography
05/06/2004EP1414862A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation
05/06/2004EP1414861A2 Humanized antibodies against icam-1, their production and uses
05/06/2004EP1414860A2 Pan-specific monoclonal antibody
05/06/2004EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
05/06/2004EP1414856A2 Modified calcitonin
05/06/2004EP1414853A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon
05/06/2004EP1414852A2 Human secreted proteins, their encoding pulynucleotides, and uses thereof
05/06/2004EP1414851A2 Cellular virus receptors and methods of use.
05/06/2004EP1414850A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
05/06/2004EP1414849A2 Immune-modulating peptide
05/06/2004EP1414848A2 Replikin peptides and uses thereof
05/06/2004EP1414842A2 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
05/06/2004EP1414841A1 Oligonucleotide-containing pharmacological compositions and their use
05/06/2004EP1414840A2 Genomics applications for modified oligonucleotides
05/06/2004EP1414839A2 Antisense modulation of stearoyl-coa desaturase expression
05/06/2004EP1414838A2 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
05/06/2004EP1414500A2 Akt and regulation of ra synovial fibroblast apoptosis
05/06/2004EP1414495A1 Anti-microbial targeting chimeric pharmaceutical
05/06/2004EP1414490A1 Immunomodulatory oligonucleotide formulations and methods for use thereof
05/06/2004EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders
05/06/2004EP1414485A1 Use of corticotroph-derived glycoprotein hormone to induce lipolysis
05/06/2004EP1414478A2 Inhibition of neurodegeneration
05/06/2004EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
05/06/2004EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins
05/06/2004EP1414422A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/06/2004EP1414379A2 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
05/06/2004EP1414288A2 Sugar and lipid metabolism regulators in plants iii
05/06/2004EP1352085A4 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
05/06/2004EP1269190B1 Method for detecting and/or quantifying first molecules
05/06/2004EP1263934A4 Genetic engineering of drought tolerance via a plastid genome
05/06/2004EP1088088A4 Diacylglycerol o-acyltransferase
05/06/2004EP1007647B1 High level of expression of ingap
05/06/2004EP1005653A4 Method of producing a subtraction library